OVID (STOCKS)
Ovid Therapeutics Inc. Common Stock
$1.520000
-0.070000 (-4.40%)
Prev close: $1.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Margaret Alexander
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $195.93M
- Employees
- 23
- P/E (TTM)
- -2.93
- P/B (TTM)
- 2.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.17 | $-0.15 | -0.0171 | -11.18% |
|
Jun 2025 (Q2)
|
$-0.06 | $-0.16 | +0.1049 | +63.61% |
|
Mar 2025 (Q1)
|
$-0.14 | $-0.14 | -0.0006 | -0.43% |
|
Dec 2024 (Q4)
|
$-0.13 | $-0.17 | +0.0393 | +23.21% |
Financial Statements
| Revenues | $6.61M |
| Benefits Costs and Expenses | $42.94M |
| Costs And Expenses | $42.94M |
| Operating Expenses | $47.48M |
| Research and Development | $24.92M |
| Other Operating Expenses | $22.56M |
| Operating Income/Loss | -$40.87M |
| Income/Loss From Continuing Operations After Tax | -$36.33M |
| Income/Loss From Continuing Operations Before Tax | -$36.33M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$36.33M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$36.33M |
| Net Income/Loss Available To Common Stockholders, Basic | -$36.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$458.00K |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $63.85M |
| Current Assets | $28.82M |
| Cash | $25.60M |
| Other Current Assets | $3.22M |
| Noncurrent Assets | $35.02M |
| Fixed Assets | $269.00K |
| Other Non-current Assets | $34.76M |
| Liabilities | $19.15M |
| Current Liabilities | $6.80M |
| Accounts Payable | $1.71M |
| Wages | $1.85M |
| Other Current Liabilities | $3.24M |
| Noncurrent Liabilities | $12.35M |
| Equity | $44.70M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $44.70M |
| Liabilities And Equity | $63.85M |
| Net Cash Flow From Operating Activities | -$37.93M |
| Net Cash Flow From Operating Activities, Continuing | -$37.93M |
| Net Cash Flow From Investing Activities | $43.50M |
| Net Cash Flow From Investing Activities, Continuing | $43.50M |
| Net Cash Flow From Financing Activities | $28.00K |
| Net Cash Flow From Financing Activities, Continuing | $28.00K |
| Net Cash Flow | $5.59M |
| Net Cash Flow, Continuing | $5.59M |
| Comprehensive Income/Loss | -$36.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$36.49M |
| Other Comprehensive Income/Loss | -$21.54M |